Health News
Date: Jul-25-2013
BD (Becton, Dickinson and Company), a leading global medical technology company, announces the approval of the BD Saf-T-Intima™ Safety Integrated IV Catheter System for use in subcutaneous infusion therapies in Europe. Subcutaneous infusion is increasingly and widely used for therapies such as rehydration, post-operative pain management, palliative care and paediatric care. It provides an affordable, effective, and less invasive alternative to the established intravenous route...
Date: Jul-25-2013
The very first 'European Restart a Heart Day'-to teach members of the public how to help restart the heart of someone who has suffered a cardiac arrest-will be held this autumn, organised by the European Resuscitation Council (ERC). The initiative, which takes place on October 16, is aimed particularly at Europe's younger people, aims to improve the very low numbers of people surviving out-of-hospital cardiac arrests. On the day, Members of European Parliament will be taught how to resuscitate a victim and use an automated external defibrillator (AED)...
Date: Jul-25-2013
It's no surprise that those who tend to see a rose's blooms before its thorns are also better at handling stress. But science has failed to reliably associate optimism with individuals' biological stress response - until now. New research from Concordia University's Department of Psychology is deepening the understanding of how optimists and pessimists each handle stress by comparing them not to each other but to themselves. Results show that indeed the "stress hormone" cortisol tends to be more stable in those with more positive personalities...
Date: Jul-25-2013
A new study from mental health charity, SANE Australia, reports that stigma and discrimination against people with mental illness is widespread, harmful to recovery, and is a major barrier to participation in society for those affected. The new report - A Life without Stigma - concludes that a national strategy to tackle stigma and discrimination associated with mental illness is vital, and should be a non-negotiable component of mental health policies and plans...
Date: Jul-25-2013
Human glioblastoma multiforme, one of the most common, aggressive and deadly forms of brain cancer, is notoriously difficult to study. Scientists have traditionally studied cancer cells in petri dishes, which have none of the properties of the brain tissues in which these cancers grow, or in expensive animal models. Now a team of engineers has developed a three-dimensional hydrogel that more closely mimics conditions in the brain...
Date: Jul-25-2013
Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time. The method was used to treat Sanfilippo - a fatal inherited condition which causes progressive dementia in children - but could also benefit several neurological, genetic diseases. Researchers behind the study, published in the journal Molecular Therapy this month, are now hoping to bring a treatment to trial in patients within two years...
Date: Jul-25-2013
Disabling a protein in Ebola virus cells can stop the virus from replicating and infecting the host, according to researchers from the Icahn School of Medicine at Mount Sinai. The data are published in July in the journal Cell Host and Microbe. Ebola viruses cause severe disease in humans because they can deactivate the innate immune system. Christopher Basler, PhD, Associate Professor of Microbiology at Mount Sinai and his team have studied how Ebola viruses evade the immune system, and discovered that a viral protein called VP35 is critical to deactivating the immune system...
Date: Jul-25-2013
In degenerative brain diseases and after stroke, nerve cells die while their support cells activate the brain's immune system to cause further damage. Now Jonathan Gilthorpe, Adrian Pini and Andrew Lumsden at the MRC Centre for Developmental Neurobiology at King's College London, have found that a single protein, histone H1, causes these distinct outcomes...
Date: Jul-25-2013
The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale. The study is published in The Lancet Neurology. The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry...
Date: Jul-25-2013
Positive results from three new studies on human-animal interaction (HAI) were presented at the triennial conference of the International Association of Human-Animal Interaction Organizations (IAHAIO) in Chicago, IL. The studies, supported by funding from Mars and the WALTHAM® Centre for Pet Nutrition (WALTHAM®), examined how pets impact our physical and emotional well-being and our social relationships and community connectedness...